Josefina Serrano

1.9k total citations
39 papers, 628 citations indexed

About

Josefina Serrano is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Josefina Serrano has authored 39 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 11 papers in Immunology and 6 papers in Genetics. Recurrent topics in Josefina Serrano's work include Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Josefina Serrano is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Josefina Serrano collaborates with scholars based in Spain, United States and Switzerland. Josefina Serrano's co-authors include Carmen Martín, Concha Herrera, Francisco Martínez, Joaquín Sánchez, Antonio Torres, António Torres, Maria Gracia Gonzalez, Juan Maldonado, Antonio Jiménez and Joaquín Sánchez‐García and has published in prestigious journals such as Blood, eLife and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Josefina Serrano

36 papers receiving 621 citations

Peers

Countries citing papers authored by Josefina Serrano

Since Specialization

Citations

This map shows the geographic impact of Josefina Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josefina Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josefina Serrano more than expected).

Fields of papers citing papers by Josefina Serrano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josefina Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josefina Serrano. The network helps show where Josefina Serrano may publish in the future.

Co-authorship network of co-authors of Josefina Serrano

This figure shows the co-authorship network connecting the top 25 collaborators of Josefina Serrano. A scholar is included among the top collaborators of Josefina Serrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josefina Serrano. Josefina Serrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice 2023 ·Journal of Personalized Medicine ·Fernando Ramos, (unknown), (unknown), Pilar Martı́nez, (unknown), Manuel Barrios, (unknown), Teresa Bernal, (unknown), (unknown), (unknown), Teresa Caballero‐Velázquez, Bernardo González, Albert Altés, (unknown), Pascual Fernández, María Antonia Durán, Rocío López, Montserrat Rafel, Josefina Serrano	1
2	Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse? 2023 ·Cancers ·(unknown), (unknown), Joaquín Sánchez‐García, (unknown), (unknown), (unknown), Juana Serrano‐López, Josefina Serrano	5
3	Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics 2021 ·eLife ·Juana Serrano‐López, Shailaja Hegde, Sachin Kumar, Josefina Serrano, Jing Fang, Ashley M. Wellendorf, Paul A. Roche, (unknown), (unknown), Hartmut Geiger, H. Leighton Grimes, Sanjiv A. Luther, Ivan Maillard, Joaquín Sánchez‐García, Daniel T. Starczynowski, José A. Cancelas	4
4	Machine learning applied to gene expression analysis of T-lymphocytes in patients with cGVHD 2020 ·Bone Marrow Transplantation ·Juana Serrano‐López, (unknown), Eva Lumbreras, Josefina Serrano, (unknown), Carmen Martín, Jesús María Hernández‐Rivas, Joaquín Sánchez‐García	6
5	Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia 2020 ·Cancers ·(unknown), Fakhri Hassouneh, Nelson López-Sejas, Alejandra Pera, Beatriz Sánchez-Correa, (unknown), Juan Bergua, María José Arcos, Helena Bañas, Ignacio Casas-Avilés, Joaquín Sánchez‐García, Josefina Serrano, Carmen Martín, Esther Durán, Corona Alonso, Rafael Solana, Raquel Tarazona	28
6	Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae 2016 ·Journal of Antimicrobial Chemotherapy ·Isabel Machuca, Belén Gutiérrez‐Gutiérrez, (unknown), Irene Gracia-Ahufinger, Josefina Serrano, (unknown), J.M. Barcala, Fernando Rodríguez-López, Jesús Rodríguez‐Baño, Julián Torre‐Cisneros	36
7	Why study synesthesia? What can that teach us about ourselves? 2014 ·Josefina Serrano	0
8	Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia 2013 ·Haematologica ·Juana Serrano‐López, Josefina Serrano, (unknown), (unknown), (unknown), (unknown), (unknown), Joaquín Sánchez‐García	6
9	Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles. 2013 ·PubMed ·Javier de la Serna, Isidro Jarque, Javier López‐Jiménez, (unknown), Gómez, M. Jurado, Andrés Pascual, Josefina Serrano, (unknown), Carlos Vallejo	5
10	Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL 2012 ·Bone Marrow Transplantation ·Joaquín Sánchez‐García, Josefina Serrano, Juana Serrano‐López, (unknown), Francisco Martínez, José Manuel García-Castellano, (unknown), Carmen Martín, (unknown), (unknown), (unknown), (unknown), (unknown)	22
11	Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia 2011 ·Transfusion ·Juana Serrano‐López, Joaquín Sánchez‐García, Josefina Serrano, (unknown), José Manuel García-Castellano, José Román‐Gómez, Olga de la Rosa, (unknown), (unknown)	7
12	Tumor necrosis factor‐α‐secreting CD16+ antigen presenting cells are effectively removed by granulocytapheresis in ulcerative colitis patients 2010 ·Journal of Gastroenterology and Hepatology ·Joaquín Sánchez‐García, Juana Serrano‐López, Valle García-Sánchez, (unknown), (unknown), C Pérez-Seoane, (unknown), Josefina Serrano, (unknown), (unknown)	7
13	Kinetic of regulatory CD25^high and activated CD134⁺ (OX40) T lymphocytes during acute and chronic graft‐versus‐host disease after allogeneic bone marrow transplantation 2004 ·British Journal of Haematology ·Joaquín Sánchez, (unknown), Miguel A. Álvarez, José Román‐Gómez, Carmen Martín, Francisco Martínez, Pedro Gómez, Josefina Serrano, Concha Herrera, António Torres	57
14	Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation 2002 ·British Journal of Haematology ·Joaquín Sánchez, Josefina Serrano, Pedro Gómez, Francisco Martínez, Carmen Martín, Luís Madero, Concha Herrera, José M. Garcia, (unknown), Antonio Torres	56
15	Genetic, phenotypic and clinical features of acute lymphoblastic leukemias expressing myeloperoxidase mRNA detected by RT-PCR 1999 ·Leukemia ·Josefina Serrano, (unknown), Antonio Jiménez, J A Castillejo, (unknown), (unknown), (unknown), Carmen Martín, Juan Maldonado, António Torres	16
16	Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse 1999 ·Bone Marrow Transplantation ·Josefina Serrano, (unknown), Concha Herrera, J A Castillejo, (unknown), (unknown), Maria Gracia Gonzalez, (unknown), (unknown), (unknown), Armando Torres	24
17	Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft 1999 ·Bone Marrow Transplantation ·Concha Herrera, A. Torres, José Manuel García-Castellano, (unknown), Carmen Martín, Josefina Serrano, María Falcón Romero, Miguel A. Álvarez, P Gómez, Francisco Martínez	25
18	Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome 1998 ·Bone Marrow Transplantation ·Carmen Martín, A. Torres, (unknown), Vicente Rubio, (unknown), Concha Herrera, (unknown), (unknown), (unknown), Raquel Munhoz da Silveira Campos, Josefina Serrano, René Romero, (unknown), (unknown), Ricardo J. Flores, María Falcón Romero, Francisco Martínez, P Gómez	26
19	Autologous reconstitution with BCR-ABL-negative haematopoiesis after T cell-depleted allogeneic BMT for CML 1998 ·Bone Marrow Transplantation ·Josefina Serrano, (unknown), J A Castillejo, (unknown), (unknown), Carmen Martín, Concha Herrera, A. Torres	5
20	Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation 1997 ·Bone Marrow Transplantation ·(unknown), A. Torres, Josefina Serrano, (unknown), Carmen Martín, (unknown), Francisco Martínez, P Gómez	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact